FDA Issues Safety Alert for Squamous Cell Carcinoma and Various Lymphomas in Scar Tissue around Breast Implants
The following statement is attributed to Binita Ashar, M.D., director of the Office of Surgical and Infection Control Devices in the FDA’s Center for Devices and Radiological Health
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.